Filing Details
- Accession Number:
- 0001144204-13-054043
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-04 16:18:03
- Reporting Period:
- 2013-09-30
- Filing Date:
- 2013-10-04
- Accepted Time:
- 2013-10-04 16:18:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070336 | Achillion Pharmaceuticals Inc | ACHN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1315082 | Ra Capital Healthcare Fund Lp | C/O Ra Capital Management, Llc 20 Park Plaza, Suite 1200 Boston MA 02116 | No | No | Yes | Yes | |
1346824 | Ra Capital Management, Llc | C/O Ra Capital Management, Llc 20 Park Plaza, Suite 1200 Boston MA 02116 | No | No | Yes | Yes | |
1384859 | Peter Kolchinsky | C/O Ra Capital Management, Llc 20 Park Plaza, Suite 1200 Boston MA 02116 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2013-09-30 | 1,134,397 | $2.96 | 12,791,458 | No | 4 | P | Indirect | See footnotes |
Common Stock, $0.001 Par Value | Acquisiton | 2013-09-30 | 365,603 | $2.99 | 13,157,061 | No | 4 | P | Indirect | See footnotes |
Common Stock, $0.001 Par Value | Acquisiton | 2013-09-30 | 300,000 | $3.00 | 13,457,061 | No | 4 | P | Indirect | See footnotes |
Common Stock, $0.001 Par Value | Acquisiton | 2013-09-30 | 1,000,000 | $3.01 | 14,457,061 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
Footnotes
- The securities purchased include 880,293 shares for RA Capital Healthcare Fund, L.P. (the "Fund") and 254,104 shares for an account owned by Blackwell Partners, LLC (the "Blackwell Account").
- The securities purchased include 238,708 shares for the Fund and 81,895 shares for the Blackwell Account.
- The securities purchased include 232,801 shares for the Fund and 67,199 shares for the Blackwell Account.
- The securities purchased include 775,998 shares for the Fund and 224,002 shares for the Blackwell Account.
- Following the transactions set forth on Table I above, 11,117,055 shares are held by the Fund, and 3,340,006 shares are held in the Blackwell Account.
- RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Blackwell Account. Peter Kolchinsky is the sole manager of the Adviser. In their respective capacities, each of Mr. Kolchinsky and the Adviser may be deemed to beneficially own the reported securities.
- Pursuant to Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the "Act"), each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of their respective pecuniary interests therein. The filing of this Form 4 shall not be construed as an admission that Mr. Kolchinsky or the Adviser is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of securities reported herein.